Pharmabiz

AIOCD seeks PM’s intervention to stop illegal e-pharmacies & withdraw proposed regulations GSR 817 & 220

AIOCD seeks PM’s intervention to stop illegal e-pharmacies & withdraw proposed regulations GSR 817 & 220: Peethaambaran ...
Pharmabiz

Roche expands automated mass spectrometry menu with antibiotics drug monitoring CE mark approval offering industry’s broadest in vitro diagnostic menu

Roche expands automated mass spectrometry menu with antibiotics drug monitoring CE mark approval offering industry’s broadest in vitro diagnostic menu: Basel Friday, December 12 ...
Pharmabiz

Pfizer announces Tukysa added to first-line maintenance therapy extends median PFS by over 8 months in patients with HER2+ metastatic breast cancer

Pfizer announces Tukysa added to first-line maintenance therapy extends median PFS by over 8 months in patients with HER2+ metastatic breast cancer: New York Friday, December 12, ...
Pharmabiz

China NMPA approves Sanofi’s Qfitlia for haemophilia and Cablivi for acquired thrombotic thrombocytopenic purpura

China NMPA approves Sanofi’s Qfitlia for haemophilia and Cablivi for acquired thrombotic thrombocytopenic purpura: Paris Friday, December 12, 2025, 09:00 Hrs [IST] The National ...
Pharmabiz

APTI Karnataka to strengthen academic-industry synergies at IPC 2025 to be held from Dec 19-21 in Bengaluru

APTI Karnataka to strengthen academic-industry synergies at IPC 2025 to be held from Dec 19-21 in Bengaluru: Nandita Vijayasimha, Bengaluru Friday, December 12, 2025, 08:00 Hrs [I ...
Pharmabiz

KPCMA urges state govt to revise D Pharm fees from Rs. 14,300 to Rs. 40,000 to cover operational costs

KPCMA urges state govt to revise D Pharm fees from Rs. 14,300 to Rs. 40,000 to cover operational costs: Nandita Vijayasimha, Bengaluru Friday, December 12, 2025, 08:00 Hrs [IST] T ...
Pharmabiz

DGFT issues updated list of PSIAs and approved instruments to ensure regulatory compliance

DGFT issues updated list of PSIAs and approved instruments to ensure regulatory compliance: Shardul Nautiyal, Mumbai Friday, December 12, 2025, 08:00 Hrs [IST] The Directorate Gen ...
Pharmabiz

NHSA of China adds generic lecanemab in its commercial insurance innovative drug list to treat early Alzheimer’s disease

NHSA of China adds generic lecanemab in its commercial insurance innovative drug list to treat early Alzheimer’s disease: Tokyo Thursday, December 11, 2025, 16:00 Hrs [IST] Toky ...
Pharmabiz

Senores Pharma bags Pharmaceutical Excellence Award at Hurun Stars of Gujarat 2025

Senores Pharma bags Pharmaceutical Excellence Award at Hurun Stars of Gujarat 2025: Our Bureau, Bengaluru Thursday, December 11, 2025, 17:30 Hrs [IST] Senores Pharmaceuticals is i ...
Pharmabiz

Quanterix-Lucent & Emocog enter exclusive Korea distribution agreement for Simoa platform for blood-based Alzheimer’s diagnostics

Quanterix-Lucent & Emocog enter exclusive Korea distribution agreement for Simoa platform for blood-based Alzheimer’s diagnostics: Seoul, Republic of Korea Thursday, December 11 ...
Pharmabiz

Arrowhead Pharma doses first subjects in phase 1/2a study of ARO-MAPT to treat Alzheimer’s disease and other tauopathies

Arrowhead Pharma doses first subjects in phase 1/2a study of ARO-MAPT to treat Alzheimer’s disease and other tauopathies: Pasadena, California Thursday, December 11, 2025, 12:00 ...
Pharmabiz

TempraMed signs agreement with Maccabi Healthcare Services to distribute vacuum insulator devices VIVI Cap and VIVI EPI

TempraMed signs agreement with Maccabi Healthcare Services to distribute vacuum insulator devices VIVI Cap and VIVI EPI: Vancouver, British Columbia Thursday, December 11, 2025, 1 ...